Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone

C.J.  Lee; J.L.  Pallisgaard; G.H. Gislason; Christian Torp-Pedersen; A. Brandes; S Husted; S.P. Johnsen; M.L. Hansen

doi:10.1093/eurheartj/ehv400

Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone

C.J. Lee, J.L. Pallisgaard, G.H. Gislason, Christian Torp-Pedersen, A. Brandes, S Husted, S.P. Johnsen, M.L. Hansen

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	3277
Journal	European Heart Journal
Volume	36
Issue number	Suppl. 1
Pages (from-to)	544-545
Number of pages	2
ISSN	0195-668X
DOIs	https://doi.org/10.1093/eurheartj/ehv400
Publication status	Published - 2015
Event	ESC Congress - London, United Kingdom Duration: 29 Aug 2015 → 2 Sept 2015

Conference

Conference	ESC Congress
Country/Territory	United Kingdom
City	London
Period	29/08/2015 → 02/09/2015

Access to Document

10.1093/eurheartj/ehv400

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Lee, C. J., Pallisgaard, J. L., Gislason, G. H., Torp-Pedersen, C., Brandes, A., Husted, S., Johnsen, S. P., & Hansen, M. L. (2015). Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone. European Heart Journal, 36(Suppl. 1), 544-545. Article 3277. https://doi.org/10.1093/eurheartj/ehv400

@article{06a5b77776eb4dce9a6db9f4a3a0a73a,

title = "Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone",

author = "C.J. Lee and J.L. Pallisgaard and G.H. Gislason and Christian Torp-Pedersen and A. Brandes and S Husted and S.P. Johnsen and M.L. Hansen",

year = "2015",

doi = "10.1093/eurheartj/ehv400",

language = "English",

volume = "36",

pages = "544--545",

journal = "European Heart Journal",

issn = "0195-668X",

publisher = "Oxford University Press",

number = "Suppl. 1",

note = "ESC Congress ; Conference date: 29-08-2015 Through 02-09-2015",

}

Lee, CJ, Pallisgaard, JL, Gislason, GH, Torp-Pedersen, C, Brandes, A, Husted, S, Johnsen, SP & Hansen, ML 2015, 'Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone', European Heart Journal, vol. 36, no. Suppl. 1, 3277, pp. 544-545. https://doi.org/10.1093/eurheartj/ehv400

Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone. / Lee, C.J. ; Pallisgaard, J.L. ; Gislason, G.H. et al.
In: European Heart Journal, Vol. 36, No. Suppl. 1, 3277, 2015, p. 544-545.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

TY - ABST

T1 - Lower risk of myocardial infarction in atrial fibrillation patients treated with vitamin K antagonist than in combination with acetylsalicylic acid (ASA) or ASA alone

AU - Lee, C.J.

AU - Pallisgaard, J.L.

AU - Gislason, G.H.

AU - Torp-Pedersen, Christian

AU - Brandes, A.

AU - Husted, S

AU - Johnsen, S.P.

AU - Hansen, M.L.

PY - 2015

Y1 - 2015

U2 - 10.1093/eurheartj/ehv400

DO - 10.1093/eurheartj/ehv400

M3 - Conference abstract in journal

SN - 0195-668X

VL - 36

SP - 544

EP - 545

JO - European Heart Journal

JF - European Heart Journal

IS - Suppl. 1

M1 - 3277

T2 - ESC Congress

Y2 - 29 August 2015 through 2 September 2015

ER -